Riverside Partners exits BioAgilytix

Riverside Partners has sold BioAgilytix to Cobepa. No financial terms were disclosed. Based in North Carolina's Research Triangle area and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers and cell-based assay services.

11 December 2018•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles